Avecho Biotechnology Limited
Avecho Biotechnology Limited
Your view on AVE.AX
Overview
What the company does, where it operates, and who runs it.
About Avecho Biotechnology Limited
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Paul Gavin
- Headquarters
- Hallmarc Business Park, Clayton, VIC, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Paul Gavin
- Headquarters
- Hallmarc Business Park, Clayton, VIC, AU
Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments.
The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches.
In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals.
The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Avecho Biotechnology Limited. Starting points for Avecho Biotechnology Limited: beta 1.13 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Avecho Biotechnology Limited. Avecho Biotechnology Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Avecho Biotechnology Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2011 | Next quarterDec 2012 | This yearYear to Dec 2011 | Next yearYear to Dec 2012 |
|---|---|---|---|---|
| Average estimate | −AUD 0.01 | −AUD 0.01 | −AUD 0.01 | −AUD 0.01 |
| Lowest estimate | −AUD 0.01 | −AUD 0.01 | −AUD 0.01 | −AUD 0.01 |
| Highest estimate | −AUD 0.01 | −AUD 0.01 | −AUD 0.01 | −AUD 0.01 |
| Number of analysts | 3 | 3 | 3 | 3 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Revenue estimates
| Total | This quarterDec 2011 | Next quarterDec 2012 | This yearYear to Dec 2011 | Next yearYear to Dec 2012 |
|---|---|---|---|---|
| Average estimate | AUD 4.44M | AUD 3.88M | AUD 4.44M | AUD 3.88M |
| Lowest estimate | AUD 4.25M | AUD 3.40M | AUD 4.25M | AUD 3.40M |
| Highest estimate | AUD 4.46M | AUD 4.23M | AUD 4.46M | AUD 4.23M |
| Number of analysts | 2 | 3 | 2 | 3 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Avecho Biotechnology Limited. Avecho Biotechnology Limited has reported as a listed company since 1993. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| BTC.AXBTC Health Limited | Healthcare | Biotechnology | — | ||
| ENL.AXEnlitic, Inc. | Healthcare | Medical - Healthcare Information Services | — | ||
| FRE.AXFirebrick Pharma Limited | Healthcare | Drug Manufacturers - General | — | ||
| IMC.AXImmuron Limited | Healthcare | Biotechnology | — | ||
| NC6.AXNanollose Limited | Healthcare | Biotechnology | — | ||
| NTI.AXNeurotech International Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PHMMFPharma Mar, S.A. | Healthcare | OTC | $1.5B | ||
| PHRM.CNPharmaTher Holdings Ltd. | Healthcare | CNQ | $9.1M | ||
| PHRRFPharmaTher Holdings Ltd. | Healthcare | OTC | $5.3M | ||
| PHVSPharvaris N.V. | Healthcare | NASDAQ | $2.2B | ||
| PHYOFIXICO plc | Healthcare | OTC | $6.5M | ||
| PKTXProtoKinetix, Incorporated | Healthcare | OTC | $2.7M | ||
| PLRXPliant Therapeutics, Inc. | Healthcare | NASDAQ | $41.0M | ||
| PLRZPolyrizon Ltd. | Healthcare | NASDAQ | $12.4M | ||
| PLURPluri Inc. | Healthcare | NASDAQ | $9.9M | ||
| PLXProtalix BioTherapeutics, Inc. | Healthcare | AMEX | $254.6M | ||
| PLYXPolaryx Therapeutics, Inc. Common Stock | Healthcare | NASDAQ | $80.3M | ||
| PMCBPharmaCyte Biotech, Inc. | Healthcare | NASDAQ | $3.0M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Avecho Biotechnology Limited.